Anna-maria Georgoudaki
Stockholm, AB, Sweden
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 19 publications
Bulk and single-cell transcriptomics identify gene signatures of stem cell-derived NK cell donors with superior cytolytic activity.
Journal: Molecular therapy. Oncology
Published: February 28, 2024
Natural killer cells in clinical development as non-engineered, engineered, and combination therapies.
Journal: Journal of hematology & oncology
Published: August 31, 2022
ALPL-1 is a target for chimeric antigen receptor therapy in osteosarcoma.
Journal: Nature communications
Published: April 17, 2022
Adoptive NK Cell Therapy: A Promising Treatment Prospect for Metastatic Melanoma.
Journal: Cancers
Published: August 12, 2021
Boosting Natural Killer Cell Therapies in Glioblastoma Multiforme Using Supramolecular Cationic Inhibitors of Heat Shock Protein 90.
Journal: Frontiers in molecular biosciences
Published: August 06, 2021
Sarcoma Tumor Microenvironment.
Journal: Advances in experimental medicine and biology
Published: January 01, 2020
Boosting Natural Killer Cell-Mediated Targeting of Sarcoma Through DNAM-1 and NKG2D.
Journal: Frontiers in immunology
Published: July 15, 2019
Successive crystal structure snapshots suggest the basis for MHC class I peptide loading and editing by tapasin.
Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: February 28, 2019
Engineering antigen-specific NK cell lines against the melanoma-associated antigen tyrosinase via TCR gene transfer.
Journal: European journal of immunology
Published: February 12, 2019
Last Updated: 09/26/2026